On ECHEMI
Home > Drugs > Wuhan Hiteck Biological Pharma Co., Ltd.
Wuhan Hiteck Biological Pharma Co., Ltd.
  • Founded in:

    1992-04-08
  • Country:

    China China
  • Address:

    Wuhan Economic and Technological Development Zone Haite Technology Park
  • Tax NO.:

    91420100724667038L
  • Registered Funds:

    130.894391 yuan
  • Website:

  • Email:

Related Drugs
Cyclic Adenosine Monophosphate for Injection
Cyclic AMP
Name Description Content CAS NO. Registered Holders
Cyclic AMP

It is a protein kinase activator and a derivative of nucleotides. It is an important substance with physiological activity that is widely present in the human body. It is produced by adenosine triphosphate under the catalysis of adenylate cyclase and can regulate various functional activities of cells. As the second messenger of hormones, it plays a role in regulating physiological functions and material metabolism in cells, can change the function of cell membranes, promote calcium ions in reticulum to enter muscle fibers, thereby enhancing myocardial contraction, and can promote the activity of respiratory chain oxidases, improve myocardial hypoxia, relieve symptoms of coronary heart disease and improve electrocardiograms. In addition, it plays an important role in regulating sugar, fat metabolism, nucleic acid, and protein synthesis.

More

It is a protein kinase activator and a derivative of nucleotides. It is an important substance with physiological activity that is widely present in the human body. It is produced by adenosine triphosphate under the catalysis of adenylate cyclase and can regulate various functional activities of cells. As the second messenger of hormones, it plays a role in regulating physiological functions and material metabolism in cells, can change the function of cell membranes, promote calcium ions in reticulum to enter muscle fibers, thereby enhancing myocardial contraction, and can promote the activity of respiratory chain oxidases, improve myocardial hypoxia, relieve symptoms of coronary heart disease and improve electrocardiograms. In addition, it plays an important role in regulating sugar, fat metabolism, nucleic acid, and protein synthesis.

60-92-4 12
Pentoxifylline for injection
alpha;-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha;-isopropylbenzeneacetonitrile hydrochloride Molecular formula: C27H38N2O4.HCL Molecular weight: 491.07
Name Description Content CAS NO. Registered Holders
(+/-)-Verapamil hydrochloride

1. Calcium ion antagonist, regulating calcium ion influx on the membrane of myocardial conduction cells, myocardial contractile cells and arterial smooth muscle cells, without changing serum calcium concentration. 2. Dilates the main coronary artery and arterioles, antagonizes coronary artery spasm, increases myocardial oxygen delivery, reduces myocardial oxygen consumption, and is used to treat variant angina and unstable angina. 3. Prolongs the effective refractory period of the atrioventricular node, slows conduction, reduces the ventricular rate of patients with chronic atrial fibrillation and atrial flutter, and reduces the frequency of paroxysmal supraventricular tachycardia. 4. Reduces systemic vascular resistance to lower blood pressure, generally does not cause postural hypotension or reflex tachycardia. 5. Reduces afterload, inhibits myocardial contraction, and improves left ventricular diastolic function, but may aggravate the condition of patients with severe left ventricular dysfunction. 6. Has local anesthetic effect, 1.6 times the molar value of procaine (animal test), and the effect and dosage in humans are still unclear.

More

1. Calcium ion antagonist, regulating calcium ion influx on the membrane of myocardial conduction cells, myocardial contractile cells and arterial smooth muscle cells, without changing serum calcium concentration. 2. Dilates the main coronary artery and arterioles, antagonizes coronary artery spasm, increases myocardial oxygen delivery, reduces myocardial oxygen consumption, and is used to treat variant angina and unstable angina. 3. Prolongs the effective refractory period of the atrioventricular node, slows conduction, reduces the ventricular rate of patients with chronic atrial fibrillation and atrial flutter, and reduces the frequency of paroxysmal supraventricular tachycardia. 4. Reduces systemic vascular resistance to lower blood pressure, generally does not cause postural hypotension or reflex tachycardia. 5. Reduces afterload, inhibits myocardial contraction, and improves left ventricular diastolic function, but may aggravate the condition of patients with severe left ventricular dysfunction. 6. Has local anesthetic effect, 1.6 times the molar value of procaine (animal test), and the effect and dosage in humans are still unclear.

152-11-4 13
Enoxacin Gluconate for Injection
The main ingredient of this product is enoxacin gluconate. Its chemical name is: 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid-D-gluconate monohydrate.
Name Description Content CAS NO. Registered Holders
ENOXACIN GLUCONATE

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

104142-71-4 26
Enoxacin Gluconate for Injection
The main ingredient of this product is enoxacin gluconate. Its chemical name is: 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid-D-gluconate monohydrate.
Name Description Content CAS NO. Registered Holders
ENOXACIN GLUCONATE

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

104142-71-4 26
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.